Cargando…

A New Chimeric Natriuretic Peptide, C(N)AA(C), for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction

An innovative natriuretic peptide analog named C(N)AA(C) (structurally consisting of the C-terminus and ring of ANP and the N-terminus of CNP) that has been shown to exhibit potent vasodilatory, diuretic, and hypotensive effects in our previous study was evaluated for the treatment of left ventricul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shu-Miao, Zhao, Hong-Lin, Gu, Xiao-Ming, Li, Juan, Feng, Na, Wang, Yue-Min, Fan, Rong, Chen, Wen-Sheng, Pei, Jian-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577105/ https://www.ncbi.nlm.nih.gov/pubmed/28855643 http://dx.doi.org/10.1038/s41598-017-10748-6

Ejemplares similares

The Role of Natriuretic Peptides for the Diagnosis of Left Ventricular Dysfunction
por: Palazzuoli, Alberto, et al.
Publicado: (2013)

Relation of left atrial peak systolic strain with left ventricular diastolic dysfunction and brain natriuretic peptide level in patients presenting with ST-elevation myocardial infarction
por: Dogan, Cem, et al.
Publicado: (2013)

Natriuretic Peptides in Assessment of Ventricular Dysfunction
por: Gorenjak, Maksimiljan
Publicado: (2003)

Meta-Analysis of the Effects of Recombinant Human Brain Natriuretic Peptides on Left Ventricular Remodeling in Patients with Acute Myocardial Infarction
por: Zhu, Ping
Publicado: (2022)

AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions
por: Chen, Bao-Ying, et al.
Publicado: (2011)

Relationship of Left Atrial Global Peak Systolic Strain with Left Ventricular Diastolic Dysfunction and Brain Natriuretic Peptide Level in Patients Presenting with Non-ST Elevation Myocardial Infarction
por: Değirmenci, Hüsnü, et al.
Publicado: (2014)

Retracted: Meta-Analysis of the Effects of Recombinant Human Brain Natriuretic Peptides on Left Ventricular Remodeling in Patients with Acute Myocardial Infarction
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Optimal Timing of Surgical Revascularization for Myocardial Infarction and Left Ventricular Dysfunction
por: Wang, Rong, et al.
Publicado: (2017)

Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction
por: Fazlinezhad, A., et al.
Publicado: (2011)

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
por: Koschack, Janka, et al.
Publicado: (2008)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

Tetrandrine attenuates left ventricular dysfunction in rats with myocardial infarction
por: Wu, Youyang, et al.
Publicado: (2021)

B-type natriuretic peptide for the prediction of left ventricular remodelling
por: Bauters, Christophe, et al.
Publicado: (2014)

Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction
por: Yildirim, Tarik, et al.
Publicado: (2018)

Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides
por: Romano, Silvio, et al.
Publicado: (2010)

Association of C-Reactive Protein Velocity with Early Left Ventricular Dysfunction in Patients with First ST-Elevation Myocardial Infarction
por: Holzknecht, Magdalena, et al.
Publicado: (2021)

Death is associated to the type of drug-eluting stent in patients with left ventricular dysfunction and elevated natriuretic peptide levels
por: Roth, Christian, et al.
Publicado: (2021)

Diagnostic accuracy of natriuretic peptide screening for left ventricular systolic dysfunction in the community: systematic review and meta‐analysis
por: Goyder, Clare R., et al.
Publicado: (2023)

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
por: Bissessor, Naylin, et al.
Publicado: (2007)

Diagnosis and Treatment of Asymptomatic Left Ventricular Systolic Dysfunction after Myocardial Infarction
por: Ajello, Laura, et al.
Publicado: (2013)

Transient left ventricular systolic dysfunction mimicking myocardial infarction after pericardiocentesis
por: Weijers, R. W. J. H., et al.
Publicado: (2013)

Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2022)

Prognostic Significance of B-Type Natriuretic Peptide in Patients With Left Ventricular Thrombus
por: An, Zhixia, et al.
Publicado: (2021)

Pro-B-Type natriuretic peptide: a novel, specific biomarker for detection of left ventricular dysfunction in the general community
por: Macheret, Fima, et al.
Publicado: (2009)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction
por: Cao, Ye-Xuan, et al.
Publicado: (2022)

Two Problems With Analyzing Natriuretic Peptide Levels: Obesity and Acute Myocardial Infarction
por: Ahn, Min Soo, et al.
Publicado: (2010)

Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide
por: LI, JIAN, et al.
Publicado: (2013)

Retraction Notice to: Brain Natriuretic Peptide Levels in Acute Inferior Myocardial Infarction
Publicado: (2018)

The relationship between insulin resistance, serum alkaline phosphatase, and left ventricular dysfunction following myocardial infarction
por: Guo, Qifeng, et al.
Publicado: (2023)

Left ventricular diastolic dysfunction during acute myocardial infarction: Effect of mild hypothermia()
por: Schwarzl, Michael, et al.
Publicado: (2012)

Improving medication optimisation in left ventricular systolic dysfunction after acute myocardial infarction
por: Forsyth, Paul, et al.
Publicado: (2019)

Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction
por: Panicker, Gopi Krishna, et al.
Publicado: (2020)

Left ventricular pseudoaneurysm post myocardial infarction
por: Sheikh, Wasil Rasool, et al.
Publicado: (2019)

Value of the platelet-to-lymphocyte ratio in the prediction of left ventricular thrombus in anterior ST-elevation myocardial infarction with left ventricular dysfunction
por: Zhang, Qian, et al.
Publicado: (2020)

Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
por: Docherty, Kieran F., et al.
Publicado: (2021)

A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
por: Lim, Soo Ghim, et al.
Publicado: (2013)

Impact of concurrent right ventricular myocardial infarction on outcomes among patients with left ventricular myocardial infarction
por: Liao, Huocheng, et al.
Publicado: (2020)

The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Demirelli, Selami, et al.
Publicado: (2013)

Metabonomics Analysis of Myocardial Metabolic Dysfunction in Patients with Cardiac Natriuretic Peptide Resistance
por: Chang, Pan, et al.
Publicado: (2020)

N-terminal pro-B-type natriuretic peptide and the diagnosis of left ventricular systolic dysfunction: what is the optimal cut-off?
por: Turley, A, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_qg9cqpg6aundut7mc257klepbp